Pfizer makes a $6 billion run into a new cancer drug race, 6 months after rival

marketwatch.com/story/pfizer-makes-a-6-billion-run-into-a-new-cancer-drug-race-6-months-after-rival-ec832fed

Pfizer jumps into cancer-treatment race with a $6 billion licensing deal with a China-based company, six months after Merck’s move for a lot less money.

This story appeared on marketwatch.com, 2025-05-20 15:12:00.
The Entire Business World on a Single Page. Free to Use →